glp 1 drugs alcohol Weight Loss May Also Curb Substance Use Disorders Not just obesity: GLP-1 receptor

In a multivariate model, the GLP-1-RA group was associated with 50% responder-rate at M6 (Fig

Anti-obesity Drugs Market Size and Share Anti-obesity Drugs Market Analysis by Mordor Intelligence The Anti-obesity Drugs Market size is projected to be USD 25.93 billion in 2025, USD 34.06 billion in 2026, and reach USD 133.16 billion by 2031, growing at a CAGR of 31.35% from 2026 to 2031

Weight management can be influenced by many non-modifiable factors like genetic predispositions, age, and ethnicity

The global obesity crisis, with over 650 million adults classified as obese by WHO estimates, is creating sustained demand for effective pharmacological interventions

These benefits occur through blood pressure reduction (1-5.4 mmHg lower systolic blood pressure) 10 , improved vascular function, and direct effects on the heart